NEW YORK (GenomeWeb News) – Roche today reported that sales for its diagnostics division grew 4 percent year over year at constant exchange rates for the first nine months of 2012, with molecular diagnostics showing single-digit growth and the applied science unit continuing to struggle.

For the nine months ended Sept. 30, Roche reported total diagnostics sales of CHF 7.50 billion ($8.09 billion) compared to CHF 7.10 billion for the first nine months of 2011. In Swiss francs its diagnostics sales were up 6 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.